Your browser doesn't support javascript.
loading
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.
Petracci, Elisabetta; Scarpi, Emanuela; Passardi, Alessandro; Biggeri, Annibale; Milandri, Carlo; Vecchia, Stefano; Gelsomino, Fabio; Tassinari, Davide; Tamberi, Stefano; Bernardini, Ilaria; Accettura, Caterina; Frassineti, Giovanni Luca; Amadori, Dino; Nanni, Oriana.
Afiliação
  • Petracci E; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Scarpi E; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS, via Piero Maroncelli 40, Meldola, 47014, Italy.
  • Passardi A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Biggeri A; Department of Statistics, Informatics and Applications "G. Parenti", University of Florence, Florence, Italy.
  • Milandri C; Oncology Unit, S. Giuseppe Hospital, Empoli, Italy.
  • Vecchia S; Department of Pharmacy, Guglielmo da Saliceto Hospital, Piacenza, Italy.
  • Gelsomino F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Tassinari D; Department of Oncology, Infermi Hospital, Rimini, Italy.
  • Tamberi S; Medical Oncology Unit, Department of Oncology and Hematology, Degli Infermi Hospital, Faenza, Italy.
  • Bernardini I; Oncology Department, Ramazzini Hospital, Carpi, Italy.
  • Accettura C; Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy.
  • Frassineti GL; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Amadori D; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Nanni O; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Ther Adv Med Oncol ; 12: 1758835920937427, 2020.
Article em En | MEDLINE | ID: mdl-32754229
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article